Life Sciences Times

Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis

Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer

Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline

Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs

WHOOP Expands Advanced Labs Access, Adds GRAIL’s Galleri Cancer Detection Test

Amylyx Reports Positive Phase 3 Results for Avexitide in Post-Bariatric Hypoglycemia

Brixton Biosciences Adds Industry Veterans to Board as Reneurx Nears FDA Decision

Enveda Reports Positive Phase 1 Results for ENV-308

Aizen Therapeutics Signs Oral Biologics Collaboration Worth Up to $100 Million Per Target

CitiusTech Names Dhaval Shah Acting CEO, Shyam Karunakaran President